NHLBI Cord Blood Transplantation Study Begins

October 07, 1996

The first multicenter study of umbilical cord blood transplants from unrelated, newborn donors was announced today by the National Heart, Lung, and Blood Institute of the National Institutes of Health.

The 5-year, $30 million study is designed to show whether cord blood transplantation is a safe and effective alternative to bone marrow transplantation for children and adults with a variety of cancers, blood diseases, and genetic disorders.

Said NHLBI Director Dr. Claude Lenfant, "Although earlier NHLBI studies have provided evidence that cord blood transplantation can be used for children with some cancers and genetic disorders, a myriad of scientific and ethical questions related to this procedure remain. We hope that this study will provide the answers to these questions."

Bone marrow transplantation is an effective therapy for a variety of genetic disorders and blood diseases. However, for patients who don't have a matching related donor, the current system for finding a matching unrelated donor can be a long, frustrating, and ultimately unsuccessful process. This is especially true for people from ethnic and racial minorities.

Human umbilical cord blood is a rich source of the stem and progenitor cells that are present in bone marrow, and cord blood from related donors has been successfully transplanted in many children worldwide. In addition, cord blood from unrelated donors has been successfully transplanted in 51 children in two recent U.S. studies. The cord blood units for both studies was provided by the New York Blood Center, which was funded by the NHLBI.

The new study will be conducted at three facilities that will be responsible for collecting the cord blood units and at seven centers that will perform the transplants. A data coordinating center will identify the cord blood units for transplant, as well as collect the data from the study.

The study will transplant four groups of 50-75 patients each: adults weighing more than 88 pounds (40Kg), children weighing less than 88 pounds (40 Kg), patients with cancers, and patients with other conditions currently treatable with bone marrow transplantation. The transplant centers will use standardized protocols for enrolling patients, preparing them for transplant, and treating them after the transplant.

The participating transplant centers are the Dana Farber Cancer Center, Boston; the Fred Hutchinson Cancer Research Center, Seattle; the University of California, Los Angeles (UCLA). Children's Hospital of Orange County, Orange, CA; Indiana University, Indianapolis; Duke University Medical Center, Durham, NC; and the University of Minnesota, Minneapolis.

The collection and storage centers are located at Children's Hospital of Orange County, Duke University, and UCLA.

The coordinating center is the Emmes Corporation, Potomac, Maryland.

For more information, contact the NHLBI Communications Office, 301-496-4236.

NIH/National Heart, Lung and Blood Institute

Related Bone Marrow Articles from Brightsurf:

Researchers identify the mechanism behind bone marrow failure in Fanconi anaemia
Researchers at the University of Helsinki and the Dana-Farber Cancer Institute have identified the mechanism behind bone marrow failure developing in children that suffer from Fanconi anaemia.

Nanoparticles can turn off genes in bone marrow cells
Using specialized nanoparticles, MIT engineers have developed a way to turn off specific genes in cells of the bone marrow, which play an important role in producing blood cells.

How stress affects bone marrow
Researchers from Tokyo Medical and Dental University (TMDU) identified the protein CD86 as a novel marker of infection- and inflammation-induced hematopoietic responses.

3D atlas of the bone marrow -- in single cell resolution
Stem cells located in the bone marrow generate and control the production of blood and immune cells.

Dangerous bone marrow, organ transplant complication explained
Scientists have discovered the molecular mechanism behind how the common cytomegalovirus can wreak havoc on bone marrow and organ transplant patients, according to a paper published in the journal Cell & Host Microbe.

Viagra shows promise for use in bone marrow transplants
Researchers at UC Santa Cruz have demonstrated a new, rapid method to obtain donor stem cells for bone marrow transplants using a combination of Viagra and a second drug called Plerixafor.

Bone marrow may be the missing piece of the fertility puzzle
A woman's bone marrow may determine her ability to start and sustain a pregnancy, report Yale researchers in PLOS Biology.

Cells that make bone marrow also travel to the womb to help pregnancy
Bone marrow-derived cells play a role in changes to the mouse uterus before and during pregnancy, enabling implantation of the embryo and reducing pregnancy loss, according to research published Sept.

Uncovering secrets of bone marrow cells and how they differentiate
Researchers mapped distinct bone marrow niche populations and their differentiation paths for the bone marrow factory that starts from mesenchymal stromal cells and ends with three types of cells -- fat cells, bone-making cells and cartilage-making cells.

Zebrafish help researchers explore alternatives to bone marrow donation
UC San Diego researchers discover new role for epidermal growth factor receptor in blood stem cell development, a crucial key to being able to generate them in the laboratory, and circumvent the need for bone marrow donation.

Read More: Bone Marrow News and Bone Marrow Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.